{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:49:46Z","timestamp":1790653786031,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabet-metabolism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.diabet.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T03:29:47Z","timestamp":1412825387000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment"],"prefix":"10.1016","volume":"40","author":[{"given":"M.K.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-J.","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.-H.","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-D.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-M.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-Y.","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2014.08.002_bib0005","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/STROKEAHA.110.600312","article-title":"Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis","volume":"42","author":"Amighi","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.diabet.2014.08.002_bib0010","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ki.2012.301","article-title":"Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients","volume":"82","author":"Liabeuf","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabet.2014.08.002_bib0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archinternmed.2007.64","article-title":"Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein","volume":"168","author":"Shinkai","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabet.2014.08.002_bib0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2013.01.016","article-title":"Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults","volume":"62","author":"Foster","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabet.2014.08.002_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-13-0003","article-title":"Serum \u03b2-2 microglobulin predicts mortality in people with diabetes","volume":"169","author":"Cheung CL1","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabet.2014.08.002_bib0030","first-page":"1462","article-title":"Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabet.2014.08.002_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.diabet.2014.08.002_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cbi.2011.08.003","article-title":"d-Ribose glycates \u03b2(2)-microglobulin to form aggregates with high cytotoxicity through a ROS-mediated pathway","volume":"194","author":"Kong","year":"2011","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.diabet.2014.08.002_bib0045","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/CIRCULATIONAHA.106.683722","article-title":"Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2014.08.002_bib0050","doi-asserted-by":"crossref","first-page":"e72073","DOI":"10.1371\/journal.pone.0072073","article-title":"Factors other than the glomerular filtration rate that determine the serum beta-2-microglobulin level","volume":"8","author":"Stanga","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2014.08.002_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1440-1797.2005.00475.x","article-title":"Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis","volume":"10","author":"Zumrutdal","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.diabet.2014.08.002_bib0060","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1681\/ASN.2005121288","article-title":"Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms","volume":"17","author":"Stehouwer CD1","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabet.2014.08.002_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3803\/EnM.2013.28.4.309","article-title":"Association between cardiac autonomic neuropathy, diabetic retinopathy and carotid atherosclerosis in patients with type 2 diabetes","volume":"28","author":"Jung","year":"2013","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.diabet.2014.08.002_bib0070","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.amjcard.2012.07.006","article-title":"Usefulness of albuminuria as predictor for coronary artery stenosis, regardless of estimated glomerular filtration rate, in patients with type 2 diabetes mellitus","volume":"110","author":"Son","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabet.2014.08.002_bib0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1291\/hypres.28.505","article-title":"Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects","volume":"28","author":"Saijo Y1","year":"2005","journal-title":"Hypertens Res"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363614001359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363614001359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T14:22:43Z","timestamp":1538144563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363614001359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1262363614001359"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2014.08.002","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}